Literature DB >> 1682895

Two RFLPs in the human protein 4.1 gene (EL1).

T K Tang1, K B Tam, S Chien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682895      PMCID: PMC329075          DOI: 10.1093/nar/19.21.6057

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  4 in total

1.  Linkage of dominant hereditary spherocytosis to the gene for the erythrocyte membrane-skeleton protein ankyrin.

Authors:  F F Costa; P Agre; P C Watkins; J C Winkelmann; T K Tang; K M John; S E Lux; B G Forget
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

2.  Selective expression of an erythroid-specific isoform of protein 4.1.

Authors:  T K Tang; T L Leto; I Correas; M A Alonso; V T Marchesi; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Rapid localization of membrane skeletal protein 4.1 (EL1) to human chromosome 1p33----p34.2 by nonradioactive in situ hybridization.

Authors:  C J Tang; T K Tang
Journal:  Cytogenet Cell Genet       Date:  1991

4.  Heterogeneity of mRNA and protein products arising from the protein 4.1 gene in erythroid and nonerythroid tissues.

Authors:  T K Tang; Z Qin; T Leto; V T Marchesi; E J Benz
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

  4 in total
  2 in total

1.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis.

Authors:  P B Jenkins; G K Abou-Alfa; D Dhermy; E Bursaux; C Féo; A L Scarpa; S E Lux; M Garbarz; B G Forget; P G Gallagher
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.